← All diseases
Infectious diseases
Chronic hepatitis B
Do you want to receive a message when there is new research about Chronic hepatitis B? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication there is one sentence that explains what was investigated — and you receive a message as soon as there is new research about Chronic hepatitis B. View what Premium costs.
Publications and studies (2004)
- Global mortality of chronic liver diseases attributable to Hepatitis B virus and Hepatitis C virus infections from 1990 to 2019 and projections to 2030. (2024/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Newer Diagnostic Virological Markers for Hepatitis B Virus Infection. (2024/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. HeberNasvac: Development and Application in the Context of Chronic Hepatitis B. (2024/07/01) ♡
- Chishao - Fuzi herbal pair restore the macrophage M1/M2 balance in acute-on-chronic liver failure. (2024/06/28) ♡
- Bushen Formula promotes the decrease of HBsAg levels in patients with CHB by regulating Tfh cells and B-cell subsets. (2024/06/28) ♡
- Plasma Adiponectin Levels in Relation to Chronic Hepatitis B Infection Progression to Liver Cancer Milestones: A Prospective Study. (2024/06/21) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hemolysis attributed to high dose vitamin C: Two case reports. (2024/06/16) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Case of Rapidly Diagnosed Mycobacterium intracellulare in a Frail Geriatric Patient With Multimorbidity. (2024/06/13) ♡
- Lipid safety of tenofovir alafenamide during 96-week treatment in treatment-naive chronic hepatitis B patients. (2024/06/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Progress of Infection and Replication Systems of Hepatitis B Virus. (2024/06/04) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Hepatitis B surface antigen seroclearance is uncommon but durable in the long run. (2024/06/01) ♡
- Long-term entecavir therapy of chronic hepatitis B in real-life setting-Importance of quantitative HBsAg level. (2024/06/01) ♡
- Causal associations between chronic viral hepatitis and psychiatric disorders: a Mendelian randomization study. (2024/05/31) ♡
- Plasma microRNA-15a/16-1-based machine learning for early detection of hepatitis B virus-related hepatocellular carcinoma. (2024/05/24) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Reply to: “A comment on `A multicenter randomized-controlled trial of nucleos (t) ide analogue cessation in HBeAg-negative chronic hepatitis B'”. (2024/05/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Letter to the Editor: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game? (2024/05/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Reply: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game? (2024/05/01) ♡
- Discovery and mechanistic study of Imperatorin that inhibits HBsAg expression and cccDNA transcription. (2024/05/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Letter: Determining optimal ALT cut-off values for predicting significant hepatic histological changes in chronic hepatitis B virus infection. (2024/05/01) ♡
- Predictive role of early treatment dynamics of HBV RNA and HBCrag for HBeAg seroconversion in children with chronic hepatitis B. (2024/05/01) ♡
- Toward the elimination of hepatitis B: networking to promote the prevention of vertical transmission of hepatitis B virus through population-based interventions and multidisciplinary groups in Africa. (2024/04/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma. (2024/04/01) ♡
- Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B. (2024/04/01) ♡
- High Incidence Rate of Computed Tomography-Measured Steatotic Liver Disease in Men With and Without HIV Infection. (2024/04/01) ♡
- Society for Maternal-Fetal Medicine Consult Series #69: Hepatitis B in pregnancy: updated guidelines. (2024/04/01) ♡
- Wuling capsule modulates macrophage polarization by inhibiting the TLR4-NF-κB signaling pathway to relieve liver fibrosis. (2024/03/10) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Silymarin Synergizes with Antiviral Therapy in Hepatitis B Virus-Related Liver Cirrhosis: A Propensity Score Matching Multi-Institutional Study. (2024/03/07) ♡
- Chronic Hepatitis B in Women of Childbearing Age and Pregnant Women in China: A Cross-Sectional Study. (2024/03/05) ♡
- Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study. (2024/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Human gut microbiota from hepatitis B virus-infected individuals is associated with reduced triglyceride level in mice: faecal transplantation study. (2024/03/01) ♡
- Machine-learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD-related liver fibrosis. (2024/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. An overview of anti-hepatitis B virus flavonoids and their mechanisms of action. (2024/02/29) ♡
- Genetic variants in the 6p21.3 region influence hepatitis B virus clearance and chronic hepatitis B risk in the Han Chinese population. (2024/02/29) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hepatocellular Carcinoma with Gastric Metastasis Mimicking a 4 cm Gastrointestinal Stromal Tumor After a 3-year Disease-free Interval. (2024/02/28) ♡
- Alanine Aminotransferase (ALT) Test. (2024/02/27) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. In Vitro Lactic Acid Bacteria Anti-Hepatitis B Virus (HBV) Effect and Modulation of the Intestinal Microbiota in Fecal Cultures from HBV-Associated Hepatocellular Carcinoma Patients (2024/02/22) ♡
- Characteristics and clinical treatment outcomes of chronic hepatitis B children with coexistence of hepatitis B surface antigen (HBsAg) and antibodies to HBsAg. (2024/02/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Classifying hepatitis B therapies with insights from covalently closed circular DNA dynamics. (2024/02/01) ♡
- Liver dysfunction and clinical outcomes of unvaccinated COVID-19 patients with and without chronic hepatitis B. (2024/02/01) ♡
- Preparing for the Next Pandemic: Increased Expression of Interferon-Stimulated Genes After Local Administration of Nasalferon or HebernaSvac. (2024/02/01) ♡
- Proteome microarray identifies autoantibody biomarkers for diagnosis of hepatitis B-related hepatocellular carcinoma. (2024/02/01) ♡
- The performance of hepatitis B surface antigen quantification as a noninvasive biomarker predicting liver injury and serum hepatitis B virus DNA level. (2024/02/01) ♡
- Serum CXCL16: A new predictor of liver inflammation in patients with chronic hepatitis B. (2024/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Renal histology of Fanconi syndrome associated with adefovir dipivoxil: A case report. (2024/02/01) ♡
- Renal function in patients with chronic hepatitis B during antiviral therapy. (2024/02/01) ♡
- The effect and mechanism of Qingre Huashi formula in the treatment of chronic hepatitis B with Gan-dan-shi-re syndrome: An integrated transcriptomic and targeted metabolomic analysis. (2024/01/30) ♡
- Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity. (2024/01/28) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical cure induced by pegylated interferon α-2b in the advantaged population of chronic hepatitis B virus infection: a retrospective cohort study. (2024/01/16) ♡
- Detection of serum large and middle hepatitis B virus surface proteins: A novel potential diagnostic and prognostic biomarker for chronic hepatitis B. (2024/01/15) ♡
- Inverse association between type 2 diabetes and hepatocellular carcinoma in East Asian populations. (2024/01/03) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.